Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Advanced glycation end product...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Advanced glycation end products (AGEs) augment production of vascular endothelial growth factor (VEGF) and tumor necrosis factor alpha (TNF alpha) in human monocyte-derived macrophages.
Bibliographic Details
Main Authors:
Pertynska-Marczewska, M
,
Kiriakidis, S
,
Foxwell, B
,
Feldmann, M
,
Paleolog, E
Format:
Conference item
Published:
2003
Holdings
Description
Similar Items
Staff View
Similar Items
Advanced glycation end products upregulate angiogenic and pro-inflammatory cytokine production in human monocyte/macrophages.
by: Pertyńska-Marczewska, M, et al.
Published: (2004)
Advanced glycation end products (AGE) enhance vascular endothelial growth factor (VEGF) production in promonocytic leukaemia THP-1 cells
by: Pertńaska-Marczewska, M, et al.
Published: (2003)
The effect of tumour necrosis factor-alpha (TNF-alpha) muteins on human neutrophils in vitro.
by: Tchorzewski, H, et al.
Published: (1993)
Tumor necrosis factor-alpha (TNF) triggers a cytokine cascade yielding postoperative cognitive decline
by: Terrando, N, et al.
Published: (2010)
Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
by: Maini, R, et al.
Published: (1995)